MX2012002343A - Agente contra la obesidad, alimento o bebida contra la obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa. - Google Patents

Agente contra la obesidad, alimento o bebida contra la obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa.

Info

Publication number
MX2012002343A
MX2012002343A MX2012002343A MX2012002343A MX2012002343A MX 2012002343 A MX2012002343 A MX 2012002343A MX 2012002343 A MX2012002343 A MX 2012002343A MX 2012002343 A MX2012002343 A MX 2012002343A MX 2012002343 A MX2012002343 A MX 2012002343A
Authority
MX
Mexico
Prior art keywords
glucose tolerance
obesity
agent
food
beverage
Prior art date
Application number
MX2012002343A
Other languages
English (en)
Inventor
Kanetada Shimizu
Shizuki Kondo
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of MX2012002343A publication Critical patent/MX2012002343A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Abstract

Un agente contra la obesidad o un agente que mejora la tolerancia a la glucosa, que contiene como ingrediente activo una bacteria que pertenece al género Bifidobacterium, en donde la bacteria que pertenece al género Bifidobacterium exhibe un índice de conversión del ácido linoléico en ácido linoléico conjugado no mayor que 10%. La presente invención puede proporcionar un agente contra la obesidad y un agente que mejora la tolerancia a la glucosa que son eficaces para la prevención o tratamiento de la obesidad o mejora de la tolerancia a la glucosa y también exhibir seguridad superior, así como el suministro de alimentos o bebidas que contienen estos agentes. Además, la presente invención también puede proporcionar una bacteria del género Bifidobacterium, y particularmente Bifidobacterium breve, que es eficaz para la prevención o el tratamiento de obesidad o mejora de tolerancia a la glucosa y también exhiba seguridad superior, así como el suministro de una composición farmacéutica que contiene esta bacteria.
MX2012002343A 2009-09-17 2010-09-17 Agente contra la obesidad, alimento o bebida contra la obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa. MX2012002343A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009215836 2009-09-17
PCT/JP2010/066193 WO2011034166A1 (ja) 2009-09-17 2010-09-17 抗肥満剤、抗肥満用飲食品、耐糖能改善剤及び耐糖能改善用飲食品

Publications (1)

Publication Number Publication Date
MX2012002343A true MX2012002343A (es) 2012-06-01

Family

ID=43758765

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002343A MX2012002343A (es) 2009-09-17 2010-09-17 Agente contra la obesidad, alimento o bebida contra la obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa.

Country Status (15)

Country Link
US (1) US8497114B2 (es)
EP (1) EP2478910B1 (es)
JP (1) JP4834798B2 (es)
KR (1) KR101384648B1 (es)
CN (1) CN102970997B (es)
AU (1) AU2010296332B2 (es)
BR (2) BR122020016728B1 (es)
CA (1) CA2774073C (es)
DK (1) DK2478910T3 (es)
ES (1) ES2647922T3 (es)
MX (1) MX2012002343A (es)
NZ (1) NZ598751A (es)
PL (1) PL2478910T3 (es)
RU (1) RU2518293C2 (es)
WO (1) WO2011034166A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6139217B2 (ja) * 2013-03-29 2017-05-31 森永乳業株式会社 Ｄ−アミノ酸の製造方法
JP6382027B2 (ja) 2014-08-26 2018-08-29 サンスター株式会社 ビフィズス菌及びアブラナ科野菜を含有する経口組成物
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
JP6650728B2 (ja) * 2015-03-06 2020-02-19 株式会社ファンケル ダイエット用の製剤
JP6853821B2 (ja) * 2016-05-31 2021-03-31 森永乳業株式会社 脳機能改善剤
JP2017216980A (ja) * 2016-06-10 2017-12-14 森永乳業株式会社 オリゴヌクレオチド
EP3549593A4 (en) * 2016-11-29 2020-08-12 Morinaga Milk Industry Co., Ltd. AGLYCON PRODUCTION PROMOTERS
AU2018225957B2 (en) * 2017-02-24 2020-10-22 Morinaga Milk Industry Co., Ltd. Composition for alleviating mental health disorder
WO2018180728A1 (ja) * 2017-03-30 2018-10-04 森永乳業株式会社 炎症制御遺伝子の発現促進用組成物
CN110831608A (zh) * 2017-06-30 2020-02-21 N·V·努特里奇亚 预防疾病的合生素组合物
WO2019087280A1 (ja) * 2017-10-31 2019-05-09 森永乳業株式会社 筋肉増量用組成物
CN111954536A (zh) * 2018-03-23 2020-11-17 森永乳业株式会社 用于预防学龄期及之后的高血糖引起的疾病的婴幼儿用组合物
US11857579B2 (en) * 2018-03-23 2024-01-02 Morinaga Milk Industry Co., Ltd. Composition for promoting the secretion of FGF21
US11825856B2 (en) * 2018-03-28 2023-11-28 Morinaga Milk Industry Co., Ltd. Composition for preventing or improving functional gastrointestinal disorders, and, pharmaceutical composition, food/beverage composition, and method of preventing or improving functional gastrointestinal disorders using the composition for preventing or improving functional gastrointestinal disorders
JP7408539B2 (ja) * 2018-03-29 2024-01-05 森永乳業株式会社 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物
JP7309436B2 (ja) * 2019-04-26 2023-07-18 森永乳業株式会社 腎機能障害予防又は改善用組成物、並びに、該腎機能障害予防又は改善用組成物を用いた医薬品組成物及び飲食品組成物
US20230218686A1 (en) * 2020-06-18 2023-07-13 Morinaga Milk Industry Co., Ltd. Cognitive Function Improving Agent, Cognitive Function Maintaining Agent, Hippocampus Function Improving Agent, and Hippocampus Function Maintaining Agent
KR102629635B1 (ko) * 2021-05-13 2024-01-30 주식회사 비티진 신규한 비피도박테리움 롱검 균주 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271223A (ja) * 1985-05-24 1986-12-01 Biofuerumin Seiyaku Kk 血中脂質改善剤
AU2002214330A1 (en) * 2000-12-05 2002-06-18 Kabushiki Kaisha Yakult Honsha Proliferation promoters for enteric bifidobacteria
WO2003087344A1 (en) 2002-04-12 2003-10-23 Chebigen Inc. New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof
JP2004137167A (ja) 2002-10-16 2004-05-13 Aaku Giken:Kk 乳酸菌生産物質とその製造方法
ES2524344T3 (es) * 2005-02-28 2014-12-05 N.V. Nutricia Composición nutritiva con probióticos
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity

Also Published As

Publication number Publication date
BR112012005768A2 (pt) 2018-03-20
EP2478910A4 (en) 2014-03-12
ES2647922T3 (es) 2017-12-27
NZ598751A (en) 2013-07-26
RU2518293C2 (ru) 2014-06-10
BR122020016728B1 (pt) 2022-01-18
CA2774073C (en) 2014-09-30
CN102970997A (zh) 2013-03-13
EP2478910A1 (en) 2012-07-25
US20120171167A1 (en) 2012-07-05
WO2011034166A1 (ja) 2011-03-24
AU2010296332B2 (en) 2013-03-14
US8497114B2 (en) 2013-07-30
CA2774073A1 (en) 2011-03-24
CN102970997B (zh) 2014-12-10
KR20120043111A (ko) 2012-05-03
JP4834798B2 (ja) 2011-12-14
RU2012109558A (ru) 2013-10-27
PL2478910T3 (pl) 2018-05-30
JPWO2011034166A1 (ja) 2013-02-14
DK2478910T3 (en) 2017-12-04
KR101384648B1 (ko) 2014-04-14
EP2478910B1 (en) 2017-11-01
AU2010296332A1 (en) 2012-04-19
BR112012005768B1 (pt) 2021-03-02

Similar Documents

Publication Publication Date Title
MX2012002343A (es) Agente contra la obesidad, alimento o bebida contra la obesidad, agente que mejora la tolerancia a la glucosa, y alimento o bebida para mejorar la tolerancia a la glucosa.
MY172363A (en) Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
WO2010087964A3 (en) Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
WO2008143182A1 (ja) 甘草ポリフェノールを含有する組成物
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
UA115520C2 (uk) Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення
WO2009112361A3 (en) Synbiotic mixture
MX337716B (es) Preparacion que contiene bacteria de acido lactico.
EP2014181A3 (en) Compositions based on prebiotic and immunogenic ingredients for the prevention and treatment of gastroenteric disorders caused by dysbiosis and/or alterations of the normal intestinal flora
TW200700074A (en) Inducer of t cell apoptosis
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
WO2014066053A3 (en) Method of prevention and treatment of clostridium difficile infection
RU2015122255A (ru) Хитин или его производные для предотвращения и/или лечения паразитарных заболеваний
EE05721B1 (et) Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
WO2011162523A3 (ko) 쌍화탕 또는 이의 유산균 발효물을 포함하는 골다공증 예방 또는 치료용 조성물
MY153932A (en) A medicinal product and treatment
WO2011073769A3 (en) Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition
WO2011126342A3 (ko) 대잎둥굴레 또는 층층갈고리둥굴레 추출물의 신규한 용도
NZ596513A (en) Bitterness suppressant
WO2011065791A3 (ko) 황기 추출물을 포함하는 대사 촉진 조성물
WO2013046031A3 (en) Lactococcus lactis strains, and bacterial preparations thereof, for the production of bioactive peptides having anti-hypertensive and cholesterol-lowering effects in mammals; nutritional and therapeutic products produced therefrom
MX340828B (es) Composición que incluye una combinación de al menos una enzima proteolítica y al menos una enzima lipolítica para usarse en la prevención de síntesis de triglicéridos.
WO2019220329A8 (en) Probiotic strain lactobacillus kefiri sgl 13 and use thereof for the prevention and treatment of intestinal inflammation and in the prevention of intestinal neoplasms
AU2018225957A1 (en) Composition for alleviating mental health disorder

Legal Events

Date Code Title Description
FG Grant or registration